Why Is MS a More Frequent Complication of EBV Infection in Females?

Shannon E Dunn1,2,3, Nuria Alvarez-Sanchez4, Lawrence Steinman5

  • 1Sunnybrook Research Institute, Toronto, Ontario, Canada.

Immunological Reviews
|April 1, 2026
PubMed

Insights

Multiple sclerosis (MS) is linked to Epstein-Barr Virus (EBV) infection, with females experiencing higher rates. EBV triggers immune responses cross-reactive to CNS antigens, potentially explaining sex differences in MS pathogenesis.

Area of Science:

  • Neuroimmunology
  • Sex Differences in Disease
  • Viral Immunology

Background:

  • Multiple sclerosis (MS) is a T helper cell-mediated autoimmune disease targeting CNS white matter.
  • MS affects females three times more often than males, with unclear etiology.
  • Epstein-Barr Virus (EBV) infection is a known trigger for MS, inducing cross-reactive immune responses.

Purpose of the Study:

  • To review the literature on MS pathogenesis, focusing on sex differences.
  • To explore the role of EBV in MS, particularly in relation to female susceptibility.
  • To highlight the need for sex-disaggregated data in MS research.

Main Methods:

  • Literature review of studies on MS, EBV, and sex differences.
  • Analysis of EBV seroprevalence and infectious mononucleosis incidence in females.
  • Examination of autoantibody and T cell responses in females with MS.

Main Results:

  • Females exhibit higher EBV seroprevalence and infectious mononucleosis rates during peak MS susceptibility years.
  • Females with MS show increased EBNA-1 cross-reactive autoantibodies and myelin-specific T helper 1 cells.
  • EBV-infected B cells may establish greater latency in females, potentially perpetuating CNS autoimmunity.

Conclusions:

  • Sex differences in EBV infection and immune responses contribute to MS pathogenesis.
  • Understanding these sex-based mechanisms is crucial for developing targeted MS therapies.
  • Future MS research must disaggregate data by sex to accelerate discoveries.